CHI recently held their Premier Next Generation Dx Summit. The Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Trends in Cancer Diagnostics, Clinical Adoption of Next Generation Diagnostics, and Molecular Diagnostics for Infectious Disease) was designed to bring together all of the major players in the Molecular Diagnostics arena. We assembled an impressive faculty of speakers from the FDA, leading Medical Centers, Universities and Public Health Laboratories. This meeting showcased advances in technology, research and diagnostic development with special emphasis on clinical adoption and value. In addition, there were two pre-conference Short Courses held in conjunction with the event. CHI recorded and produced the two courses into DVDs.
The DVDs are now available and can be yours today!
Single DVD $295
Site License $995
(SC1) CIRCULATING TUMOR CELLS AS SURROGATE ENDPOINTS IN CLINICAL TRIALS
(SC2) REALITY CHECK ON COMPANION DIAGNOSTICS
Moving Assays to The Clinic
PLENARY KEYNOTE SESSION
AINING REGULATORY APPROVAL FOR MOLECULAR DIAGNOSTIC TESTS
Alberto Gutierrez, Ph.D., Deputy Director of OIVD, Office of in Vitro Diagnostic Device Evaluation and Safety, Food & Drug Administration
Elliot Cowan, Ph.D., Chief, Product Review Branch, Division of Emerging and Transfusion Transmitted Diseases, FDA/CBER/OBRR
Corporate Support Sponsor
Additional Media Partners